Just as predicted, vaccine companies are soon planning to unveil an Ebola vaccine in response to the manufactured Ebola outbreak that’s allegedly still spreading throughout West Africa. A genetically-modified (GM) Ebola vaccine that’s currently undergoing human clinical trials will be a spray rather than an injection, and its administration, according to one virologist, “…will not require trained medical personnel.” Much like an inhaler, the novel GM Ebola vaccine will be delivered through a special “breathing device” that anyone can pick up and use without a doctor’s help.

It’s made from a common respiratory virus known as human parainfluenza virus type 3, or HPIV3, that scientists artificially engineered to contain genes from the Ebola virus. These genes purportedly encode the proteins of Ebola virus on the outside of the HPIV3 virus, prompting an immune response. Researchers publishing their work in the Journal of Clinical Investigation say the vaccine has already been tested on six rhesus macaques, whose respiratory tracts were deliberately infiltrated with the GM virus. One month later, these same monkeys were injected with a dose of Ebola virus that was 1,000 times higher than the level that would normally kill them, but they survived. MORE